Altre lingue Tenaya Therapeutics, Inc.

Azioni

TNYA

US87990A1060

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:07 12/07/2024			Variaz. 5gg	Var. 1 gen.
3,495 ^USD	-0,14%		+19,69%	+7,87%

27/06	Tenaya Therapeutics, Inc. annuncia aggiornamenti nella leadership della ricerca	CI
10/06	TENAYA THERAPEUTICS, INC. : da William Blair & Co. è Buy	ZM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Tenaya Therapeutics, Inc.(NasdaqGS:TNYA) added to Russell Microcap Growth Index	01/07
Tenaya Therapeutics, Inc.(NasdaqGS:TNYA) added to Russell 2500 Growth Index	01/07
Tenaya Therapeutics, Inc.(NasdaqGS:TNYA) added to Russell 3000E Growth Index	01/07
Tenaya Therapeutics, Inc.(NasdaqGS:TNYA) added to Russell 3000 Growth Index	01/07
Tenaya Therapeutics, Inc.(NasdaqGS:TNYA) added to Russell 2000 Growth Index	01/07
Tenaya Therapeutics, Inc.(NasdaqGS:TNYA) added to Russell Small Cap Comp Growth Index	01/07
Tenaya Therapeutics Announces Research Leadership Updates	27/06
Tenaya Therapeutics, Inc. Announces Research Leadership Updates	27/06
Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit	18/06
Tenaya Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	14/05
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting	02/05
North American Morning Briefing : Stock Futures -2-	19/03
Tenaya Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	18/03
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	18/03
Tenaya Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	18/03
Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine	18/03
Tenaya Therapeutics, Inc. Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine	18/03
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences	27/02
Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications	26/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Tenaya Therapeutics, Inc.

Azioni

TNYA

US87990A1060

Altre lingue

Filtri